BLEND LABS INC-A (BLND) Fundamental Analysis & Valuation

NYSE:BLND • US09352U1088

1.56 USD
-0.05 (-3.11%)
At close: Mar 13, 2026
1.57 USD
+0.01 (+0.64%)
After Hours: 3/13/2026, 8:11:54 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This BLND fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall BLND gets a fundamental rating of 3 out of 10. We evaluated BLND against 277 industry peers in the Software industry. The financial health of BLND is average, but there are quite some concerns on its profitability. While showing a medium growth rate, BLND is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. BLND Profitability Analysis

1.1 Basic Checks

  • BLND had positive earnings in the past year.
  • BLND had a positive operating cash flow in the past year.
  • In the past 5 years BLND always reported negative net income.
  • In the past 5 years BLND always reported negative operating cash flow.
BLND Yearly Net Income VS EBIT VS OCF VS FCFBLND Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -200M -400M -600M

1.2 Ratios

  • BLND's Return On Assets of -12.79% is on the low side compared to the rest of the industry. BLND is outperformed by 66.79% of its industry peers.
  • BLND's Return On Equity of -17.03% is in line compared to the rest of the industry. BLND outperforms 41.88% of its industry peers.
Industry RankSector Rank
ROA -12.79%
ROE -17.03%
ROIC N/A
ROA(3y)-100.49%
ROA(5y)-70.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLND Yearly ROA, ROE, ROICBLND Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

  • BLND has a Gross Margin (68.99%) which is in line with its industry peers.
  • BLND's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for BLND so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.15%
GM growth 5Y-1.85%
BLND Yearly Profit, Operating, Gross MarginsBLND Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. BLND Health Analysis

2.1 Basic Checks

  • BLND does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for BLND. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BLND Yearly Shares OutstandingBLND Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
BLND Yearly Total Debt VS Total AssetsBLND Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • BLND has an Altman-Z score of -4.11. This is a bad value and indicates that BLND is not financially healthy and even has some risk of bankruptcy.
  • BLND has a Altman-Z score of -4.11. This is amonst the worse of the industry: BLND underperforms 81.95% of its industry peers.
  • There is no outstanding debt for BLND. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.11
ROIC/WACCN/A
WACC11.18%
BLND Yearly LT Debt VS Equity VS FCFBLND Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 2.54 indicates that BLND has no problem at all paying its short term obligations.
  • BLND has a better Current ratio (2.54) than 68.23% of its industry peers.
  • A Quick Ratio of 2.54 indicates that BLND has no problem at all paying its short term obligations.
  • BLND has a better Quick ratio (2.54) than 68.95% of its industry peers.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 2.54
BLND Yearly Current Assets VS Current LiabilitesBLND Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BLND Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 112.50% over the past year.
EPS 1Y (TTM)112.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-21.83%

3.2 Future

  • Based on estimates for the next years, BLND will show a very strong growth in Earnings Per Share. The EPS will grow by 282.98% on average per year.
  • BLND is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.21% yearly.
EPS Next Y692.23%
EPS Next 2Y282.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year19.81%
Revenue Next 2Y20.21%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

BLND Yearly Revenue VS EstimatesBLND Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
BLND Yearly EPS VS EstimatesBLND Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

3

4. BLND Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 156.00 indicates a quite expensive valuation of BLND.
  • BLND's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 25.70. BLND is valued rather expensively when compared to this.
  • The Price/Forward Earnings ratio is 19.69, which indicates a rather expensive current valuation of BLND.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BLND indicates a somewhat cheap valuation: BLND is cheaper than 63.90% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of BLND to the average of the S&P500 Index (23.84), we can say BLND is valued inline with the index average.
Industry RankSector Rank
PE 156
Fwd PE 19.69
BLND Price Earnings VS Forward Price EarningsBLND Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLND Per share dataBLND EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4 0.5

4.3 Compensation for Growth

  • BLND's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BLND's earnings are expected to grow with 282.98% in the coming years.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y282.98%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BLND Dividend Analysis

5.1 Amount

  • BLND does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BLND Fundamentals: All Metrics, Ratios and Statistics

BLEND LABS INC-A

NYSE:BLND (3/13/2026, 8:11:54 PM)

After market: 1.57 +0.01 (+0.64%)

1.56

-0.05 (-3.11%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-10
Earnings (Next)N/A
Inst Owners77.86%
Inst Owner Change5.58%
Ins Owners4.02%
Ins Owner Change5.19%
Market Cap405.21M
Revenue(TTM)N/A
Net Income(TTM)-24.24M
Analysts80
Price Target4.29 (175%)
Short Float %6.2%
Short Ratio4.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-100%
Min EPS beat(2)-100%
Max EPS beat(2)-100%
EPS beat(4)1
Avg EPS beat(4)-19.36%
Min EPS beat(4)-100%
Max EPS beat(4)222.55%
EPS beat(8)4
Avg EPS beat(8)12%
EPS beat(12)7
Avg EPS beat(12)10.39%
EPS beat(16)10
Avg EPS beat(16)7.49%
Revenue beat(2)0
Avg Revenue beat(2)-2.49%
Min Revenue beat(2)-3.21%
Max Revenue beat(2)-1.77%
Revenue beat(4)0
Avg Revenue beat(4)-9.39%
Min Revenue beat(4)-30.67%
Max Revenue beat(4)-1.77%
Revenue beat(8)2
Avg Revenue beat(8)-4.38%
Revenue beat(12)4
Avg Revenue beat(12)-2.24%
Revenue beat(16)7
Avg Revenue beat(16)-0.2%
PT rev (1m)0%
PT rev (3m)-9.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-32.13%
EPS NY rev (1m)0%
EPS NY rev (3m)-24.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 156
Fwd PE 19.69
P/S 3.06
P/FCF N/A
P/OCF 68.15
P/B 2.85
P/tB 2.85
EV/EBITDA N/A
EPS(TTM)0.01
EY0.64%
EPS(NY)0.08
Fwd EY5.08%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.02
OCFY1.47%
SpS0.51
BVpS0.55
TBVpS0.55
PEG (NY)0.23
PEG (5Y)N/A
Graham Number0.35
Profitability
Industry RankSector Rank
ROA -12.79%
ROE -17.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.99%
FCFM N/A
ROA(3y)-100.49%
ROA(5y)-70.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.15%
GM growth 5Y-1.85%
F-Score6
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 511.77%
Cap/Sales 9.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.54
Quick Ratio 2.54
Altman-Z -4.11
F-Score6
WACC11.18%
ROIC/WACCN/A
Cap/Depr(3y)157.7%
Cap/Depr(5y)104.5%
Cap/Sales(3y)2.44%
Cap/Sales(5y)1.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y692.23%
EPS Next 2Y282.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-21.83%
Revenue Next Year19.81%
Revenue Next 2Y20.21%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y70.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year202.8%
EBIT Next 3Y72.9%
EBIT Next 5YN/A
FCF growth 1Y95.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y103.86%
OCF growth 3YN/A
OCF growth 5YN/A

BLEND LABS INC-A / BLND FAQ

What is the fundamental rating for BLND stock?

ChartMill assigns a fundamental rating of 3 / 10 to BLND.


What is the valuation status of BLEND LABS INC-A (BLND) stock?

ChartMill assigns a valuation rating of 3 / 10 to BLEND LABS INC-A (BLND). This can be considered as Overvalued.


How profitable is BLEND LABS INC-A (BLND) stock?

BLEND LABS INC-A (BLND) has a profitability rating of 1 / 10.


How financially healthy is BLEND LABS INC-A?

The financial health rating of BLEND LABS INC-A (BLND) is 6 / 10.